Learn more about groundbreaking Simoa technology!
Simoa technology is enabling scientists to measure baseline levels of key biomarkers relevant to COVID-19 research, including cytokines, chemokines and NfL. With the capacity to measure well above limits of quantification and directly in blood, Simoa is accelerating critical research on COVID-19 impacts and potential treatments.